ArticleJournal of medicinal chemistry2022

6-Thioguanosine Monophosphate Prodrugs Display Enhanced Performance against Thiopurine-Resistant Leukemia and Breast Cancer Cells.

Sarah Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.